Thursday, August 01, 2002 2:54:01 PM
Recent JANX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 01:18:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 01:07:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 10:32:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 10:26:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2024 11:17:16 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 11:06:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:28:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:20:47 PM
- Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights • Business Wire • 08/07/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 09:00:50 PM
- Janux Therapeutics Announces Updates to Board of Directors • Business Wire • 07/22/2024 08:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/17/2024 09:02:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 11:02:49 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/08/2024 01:13:58 PM
- Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights • Business Wire • 05/07/2024 08:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/08/2024 09:47:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 09:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:11:29 PM
- Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights • Business Wire • 03/08/2024 09:01:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 10:30:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 10:11:11 PM
- Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants • Business Wire • 02/29/2024 06:22:00 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM